Biomea Share Price

Biomea Share Price

NASDAQ: BMEA | Micro Cap | Healthcare
$0.52
+$0.04 (8.70%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Biomea Stock Performance

Open
$0.48
Prev. Close
$0.48
Circuit Range
N/A
Day Range
$0.46 - $0.52
Year Range
$0.46 - $2.23
Volume
35,492
Average Traded
$0.51

Biomea Share Price Today

As of 19 November 2026, Biomea Fusion, Inc.'s share price is $0.52. The stock opened at $0.48, compared to its previous close of $0.48. During today's trading session, Biomea Fusion, Inc.'s share price traded between $0.46 and $0.52, with an average price of $0.49. Over the past 52 weeks, the stock has recorded a high of $2.23 and a low of $0.46. In terms of performance, Biomea Fusion, Inc.'s share price has declined by 62.37% over the last six months and is down 53.05% on a year-on-year basis.

Biomea Share Price Chart

Line chart of the Biomea price trend over the selected period. The price rose overall, ranging from 0.46 to 0.52, ending at 0.52.
$0.46$0.52
L
Show Current Price
H

Biomea Stock Fundamentals & Key Indicators

Market Cap
$27.22M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.31
Revenue (TTM)
$0.00
Return On Equity (TTM)
-294.15%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-234.06%

Biomea Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit$4.61-$12.42-$8.33-$6.18
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-369.41%32.93%25.81%

Biomea Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$81.83-$117.26-$138.43-$61.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-43.30%-18.05%55.36%

Biomea Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.5211.6120.7511.49
Current Assets58.0568.33179.18117.82
Total Assets58.5779.94199.93129.31
Non Current Liabilities17.926.697.831.67
Current Liabilities11.121.6722.8619.1
Total Liabilities29.0228.3730.6920.77
Shareholders' Equity29.5551.57169.24108.54

Biomea Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-70.37-119.89-96.59-62.42
Investing0.0-0.36-2.2227.34
Financing67.91.67163.81.24

About Biomea

Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.

Biomea Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.65
$0.52
-17.69%
Oct 2026
$1.31
$0.63
-51.68%
Sep 2026
$1.68
$1.31
-22.26%
Aug 2026
$1.13
$1.69
+44.02%
Jul 2026
$1.48
$1.17
-20.41%
Jun 2026
$1.39
$1.47
+6.14%
May 2026
$1.34
$1.39
+1.84%
Apr 2026
$1.53
$1.36
-9.93%
Mar 2026
$1.37
$1.51
+10.22%
Feb 2026
$1.11
$1.37
+22.32%
Jan 2026
$1.25
$1.12
-8.94%
Dec 2025
$1.03
$1.23
+10.81%

Biomea Share Price FAQs